Novo Nordisk shares fall 8% after investor day
Novo Nordisk’s shares fell about 8% after its investor day on Monday, with Jyske Bank saying the reaction may be harsh.
Novo Nordisk's 8% share decline after the Wegovy maker's investor day on Monday suggests investors were not convinced by its growth plans, although Jyske Bank's Henrik Hallengreen Laustsen said the reaction appears somewhat harsh. He wrote that the strategy and its key components appear sound, if not...